| 2020/09/25 11:11:55 | |
|---|---|
| Price | |
| 51.17 EUR | |
| Difference | 2.58% (1.29) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 81,554 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 50.96 EUR (196) |
| Ask (Ask size) | 51.41 EUR (194) |
| Open | 51.15 EUR |
| High | 51.53 EUR |
| Low | 50.88 EUR |
| Close (prev. day) | 49.885 EUR |
| VWAP | 51.1182 EUR |
| Volume (pcs) | 1,774 |
| Trading volume | 90,683.69 |
| Number of trades | 16 |
| Last size | 15 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2020/09/01 |
|
Updates on J&J, LVMH, NVIDIA, Samsung |
|
| 2020/07/31 |
|
Global Equity Ratings |
|
| 2020/07/24 |
|
Global Equity Ratings |
|
| 2019/11/19 |
|
Měsíční strategie - akcie |
|
| 2019/10/16 |
|
Měsíční strategie - akcie |
|
| 2020/09/25 11:11:55 | |
|---|---|
| Price | |
| 51.17 EUR | |
| Difference | 2.58% (1.29) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 81,554 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 50.96 EUR (196) |
| Ask (Ask size) | 51.41 EUR (194) |
| Open | 51.15 EUR |
| High | 51.53 EUR |
| Low | 50.88 EUR |
| Close (prev. day) | 49.885 EUR |
| VWAP | 51.1182 EUR |
| Volume (pcs) | 1,774 |
| Trading volume | 90,683.69 |
| Number of trades | 16 |
| Last size | 15 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +9.28% | +9.82% | -5.88% |
| Perf (abs.) | +4.24 | +4.46 | -3.12 |
| Beta | 0.48 | 0.59 | 0.66 |
| Volatility | 24.61 | 28.81 | 27.51 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 49.95 EUR (3,091) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 51.31 EUR (2,680) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 52.42 EUR (4,108) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 53.24 EUR (5,326) |
| YTD High | date | 62.50 EUR (2020/02/13) |
| YTD Low | date | 42.60 EUR (2020/03/23) |
| 52 Weeks High | date | 62.50 EUR (2020/02/13) |
| 52 Weeks Low | date | 42.60 EUR (2020/03/23) |
All listings for BRISTOL-MYERS SQUIBB CO.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2020/09/24 | 17:35 | 49.87 EUR | 0.09 | 14 |
| Vienna Stock Exchange | 2020/09/25 | 09:08 | 51.52 EUR | 0.00 | 1 |
| Tradegate | 2020/09/25 | 11:11 | 51.17 EUR | 0.09 | 16 |
| Stuttgart | 2020/09/25 | 08:02 | 51.03 EUR | 0.00 | 1 |
| SIX Swiss Exchange | 2019/06/28 | 17:35 | 44.39 CHF | 0.00 | 1 |
| SIX Swiss Exchange | 2019/07/03 | 05:55 | 45.30 USD | 0.00 | 1 |
| NYSE | 2020/09/24 | 22:10 | 58.25 USD | 604.24 | 73,831 |
| Munich | 2020/09/25 | 08:00 | 51.00 EUR | 0.00 | 2 |
| London Stock Exchange European Trade Reporting | 2020/09/25 | 09:00 | 58.315 USD | 0.00 | 1 |
| Hanover | 2020/09/25 | 08:03 | 50.94 EUR | 0.00 | 1 |
| Hamburg | 2020/09/25 | 08:03 | 50.94 EUR | 0.00 | 1 |
| Frankfurt | 2020/09/25 | 11:23 | 50.88 EUR | 0.01 | 5 |
| Duesseldorf | 2020/09/25 | 11:30 | 50.77 EUR | 0.00 | 2 |
| Berlin | 2020/09/25 | 08:00 | 51.08 EUR | 0.00 | 1 |
Company Logo
Contact Details
| BRISTOL-MYERS SQUIBB CO. |
| - - |
| 345 Park Avenue - NY 10154 New York |
| Telefon: (212) 546-4000 |
| Fax: (212) 546-4020 |
| E-mail: - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. | |
Company Profile
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. |
Members of Management Board
| Giovanni Caforio | Chairman of Board of Directors |
| Theodore R. Samuels | Member of Board of Directors |
| Robert J. Bertolini | Member of Board of Directors |
| Phyllis Yale | Member of Board of Directors |
| Peter J. Arduini | Member of Board of Directors |
| Paula A. Price | Member of Board of Directors |
| Michael Bonney | Member of Board of Directors |
| Matthew W. Emmens | Member of Board of Directors |
| Karen H. Vousden | Member of Board of Directors |
| Gerald L. Storch | Member of Board of Directors |
| Dinesh C. Paliwal | Member of Board of Directors |
| Derica W. Rice | Member of Board of Directors |
| Vicki L. Sato | Member of Board of Directors |
| Julia A. Haller | Member of Board of Directors |
| Giovanni Caforio | Chairman of Managing Board |
| Severine Lacourt | Member of Executive Committee |
| Sandra Leung | Member of Executive Committee |
| Samit Hirawat | Member of Executive Committee |
| Rupert Vessey | Member of Executive Committee |
| Paul von Autenried | Member of Executive Committee |
| Nadim Ahmed | Member of Executive Committee |
| Lou Schmukler | Member of Executive Committee |
| Kathryn Metcalfe | Member of Executive Committee |
| Joseph E. Eid | Member of Executive Committee |
| Elizabeth A. Mily | Member of Executive Committee |